These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

374 related items for PubMed ID: 11414547

  • 1. Neurobiological mechanisms in generalized anxiety disorder.
    Nutt DJ.
    J Clin Psychiatry; 2001; 62 Suppl 11():22-7; discussion 28. PubMed ID: 11414547
    [Abstract] [Full Text] [Related]

  • 2. Role of serotonergic and noradrenergic systems in the pathophysiology of depression and anxiety disorders.
    Ressler KJ, Nemeroff CB.
    Depress Anxiety; 2000; 12 Suppl 1():2-19. PubMed ID: 11098410
    [Abstract] [Full Text] [Related]

  • 3. Magnetic resonance spectroscopy studies of GABA in neuropsychiatric disorders.
    Chang L, Cloak CC, Ernst T.
    J Clin Psychiatry; 2003; 64 Suppl 3():7-14. PubMed ID: 12662128
    [Abstract] [Full Text] [Related]

  • 4. Biological basis of generalized anxiety disorder.
    Brawman-Mintzer O, Lydiard RB.
    J Clin Psychiatry; 1997; 58 Suppl 3():16-25; discussion 26. PubMed ID: 9133489
    [Abstract] [Full Text] [Related]

  • 5. Serotonin: a common neurobiologic substrate in anxiety and depression.
    Eison MS.
    J Clin Psychopharmacol; 1990 Jun; 10(3 Suppl):26S-30S. PubMed ID: 2198299
    [Abstract] [Full Text] [Related]

  • 6. Monoamine receptor systems and anxiety disorders.
    Heninger GR, Charney DS.
    Psychiatr Clin North Am; 1988 Jun; 11(2):309-26. PubMed ID: 2843838
    [Abstract] [Full Text] [Related]

  • 7. Receptors and the mechanism of action of ECT.
    Lerer B, Belmaker RH.
    Biol Psychiatry; 1982 Apr; 17(4):497-511. PubMed ID: 6282347
    [No Abstract] [Full Text] [Related]

  • 8. Mixed depression and anxiety: serotonin1A receptors as a common pharmacologic link.
    Stahl SM.
    J Clin Psychiatry; 1997 Apr; 58 Suppl 8():20-6. PubMed ID: 9236732
    [Abstract] [Full Text] [Related]

  • 9. The neurobiology of anxiety disorders.
    Johnson MR, Lydiard RB.
    Psychiatr Clin North Am; 1995 Dec; 18(4):681-725. PubMed ID: 8748377
    [Abstract] [Full Text] [Related]

  • 10. Biochemistry of Parkinson's disease: is a brain serotonergic deficiency a characteristic of idiopathic Parkinson's disease?
    Kish SJ.
    Adv Neurol; 2003 Dec; 91():39-49. PubMed ID: 12442662
    [No Abstract] [Full Text] [Related]

  • 11. Clinical and biochemical aspects of depressive disorders: II. Transmitter/receptor theories.
    Caldecott-Hazard S, Morgan DG, DeLeon-Jones F, Overstreet DH, Janowsky D.
    Synapse; 1991 Dec; 9(4):251-301. PubMed ID: 1685032
    [Abstract] [Full Text] [Related]

  • 12. The psychobiology of posttraumatic stress disorder.
    Nutt DJ.
    J Clin Psychiatry; 2000 Dec; 61 Suppl 5():24-9; discussion 30-2. PubMed ID: 10761676
    [Abstract] [Full Text] [Related]

  • 13. Disrupted amygdalar subregion functional connectivity and evidence of a compensatory network in generalized anxiety disorder.
    Etkin A, Prater KE, Schatzberg AF, Menon V, Greicius MD.
    Arch Gen Psychiatry; 2009 Dec; 66(12):1361-72. PubMed ID: 19996041
    [Abstract] [Full Text] [Related]

  • 14. Noradrenergic and serotonergic abnormalities in depression: stress-induced dysfunction?
    Dinan TG.
    J Clin Psychiatry; 1996 Dec; 57 Suppl 4():14-8. PubMed ID: 8636061
    [Abstract] [Full Text] [Related]

  • 15. Neurotransmitters in anxiety.
    Hoehn-Saric R.
    Arch Gen Psychiatry; 1982 Jun; 39(6):735-42. PubMed ID: 6124225
    [Abstract] [Full Text] [Related]

  • 16. The development of our understanding of the mechanism of action of antidepressant drugs.
    Vetulani J.
    Pol J Pharmacol Pharm; 1991 Jun; 43(4):323-38. PubMed ID: 1811223
    [No Abstract] [Full Text] [Related]

  • 17. Anxiety and depression: a common neurobiological substrate?
    Paul SM.
    J Clin Psychiatry; 1988 Oct; 49 Suppl():13-6. PubMed ID: 2844736
    [Abstract] [Full Text] [Related]

  • 18. New developments in the neurobiological basis of anxiety disorders.
    Gorman JM, Hirschfeld RM, Ninan PT.
    Psychopharmacol Bull; 2002 Oct; 36 Suppl 2():49-67. PubMed ID: 12490823
    [Abstract] [Full Text] [Related]

  • 19. [New directions in GABAergic pharmacology of anxiety and depression].
    Kaluev AV, Nutt DD.
    Eksp Klin Farmakol; 2004 Oct; 67(6):3-7. PubMed ID: 15707004
    [Abstract] [Full Text] [Related]

  • 20. Social and neural determinants of aggressive behavior: pharmacotherapeutic targets at serotonin, dopamine and gamma-aminobutyric acid systems.
    Miczek KA, Fish EW, De Bold JF, De Almeida RM.
    Psychopharmacology (Berl); 2002 Oct; 163(3-4):434-58. PubMed ID: 12373445
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.